- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07732881
Effect of Reactive Functional Motor Challenge Training on Dynamic Balance and Functional Mobility in Children With Spastic Diplegic Cerebral Palsy: A Randomized Comparative Trial.
July 23, 2026 updated by: Omnya Samy Abdallah Ghoneim, Badr University
To investigate the effect of Reactive Functional Motor Challenge Training on dynamic balance and functional mobility in children with spastic diplegic cerebral palsy.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Cairo Governorate
-
Cairo, Cairo Governorate, Egypt
- Private clinics
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosed with spastic diplegic cerebral palsy.
- Grade 1and 1+ according to the Modified Ashworth scale.
- They can walk alone, with limitation, GMFCS Levels I-II.
- Able to follow simple verbal instructions.
Exclusion Criteria:
- Orthopedic surgery during the previous 12 months.
- Botulinum toxin injection within the previous 6 months.
- Severe cognitive impairment preventing cooperation.
- Uncontrolled epilepsy.
- Fixed musculoskeletal deformities limiting functional activities.
- Children who suffer from other diseases or associated disorders that interfere with physical activity.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Reactive Functional Motor Challenge Training,
|
The experimental group will receive Reactive Functional Motor Challenge Training using . Foam balance pads
while the control group will receive conventional physical therapy.
Outcome measures will be assessed before and after the intervention
|
|
Active Comparator: Conventional physical therapy
|
while the control group will receive conventional physical therapy.
Outcome measures will be assessed before and after the intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Paediatric Balance Scale (PBS)
Time Frame: 3 Months
|
3 Months
|
|
Four Square Step Test (FSST)
Time Frame: 3 Months
|
3 Months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Timed Up and Go (TUG)
Time Frame: 3 Months
|
3 Months
|
|
10-Meter Walk Test (10MWT)
Time Frame: 3 Months
|
3 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 13, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Study Registration Dates
First Submitted
July 19, 2026
First Submitted That Met QC Criteria
July 23, 2026
First Posted (Actual)
July 29, 2026
Study Record Updates
Last Update Posted (Actual)
July 29, 2026
Last Update Submitted That Met QC Criteria
July 23, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Study 5
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.